Representing the company’s move to foray again into the OTC pharmaceutical category, the acquisition is expected to extend and enhance the existing OTC product range.
Max Healthcare owns a range of marketing authorisations and provides own label and branded OTC medicines and products to a range of customers.
Managed in parallel with its subsidiary Brunel Healthcare Manufacturing, the Max Healthcare will operate as a subsidiary of NutraHealth.
With the majority of its manufacturing operations taking place in India, Max is mostly an outsourcing business.
Elder Pharmaceuticals is a Mumbai, India based pharmaceutical manufacturing and marketing organisation with globally accredited manufacturing facilities and an extensive marketing and distribution network.